By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

StemSynergy Therapeutics, Inc. 

1951 NW 7th Avenue
Suite 300
Miami  Florida  33136  U.S.A.
Phone: 877-556-3477 Fax: n/a


SEARCH JOBS

StemSynergy Therapeutics, Inc. (SSTI) is a biopharmaceutical company focused on the discovery of small-molecule drugs that target developmental pathways fundamental to cancer and tissue regeneration. The goal of our cancer program is to develop novel therapeutics to treat cancer by targeting cellular processes that are deregulated in cancer stem cells. Our drugs act in combination with standard-of-care agents that target the bulk of the cancer cells, with the overall aim of eliminating the cancer. SSTI is focused on breakthrough technologies in WNT, Sonic Hedgehog (SHH) and Notch signaling. With a multi-pronged scientific approach and a number of agents targeting cancer stem cell pathways, SSTI is well positioned to address critical unmet medical needs.

YEAR FOUNDED:

2007

LEADERSHIP:

Founders: Anthony J. Capobianco, Ethan Lee, David J. Robbins, and William A. Weiss


Key Statistics


Email: info@stemsynergy.com
Ownership: Private

Web Site: StemSynergy Therapeutics
Employees:
Symbol: 
 









Company News
//-->